For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $10.17 down -3.51% from its previous closing price of $10.54. In other words, the price has decreased by -$3.51 from its previous closing price. On the day, 4.0 million shares were traded. FOLD stock price reached its highest trading level at $10.47 during the session, while it also had its lowest trading level at $10.02.
Ratios:
For a deeper understanding of Amicus Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 2.78 whereas as Long-Term Debt/Eq ratio is at 2.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 19, 2023, Upgraded its rating to Overweight and sets its target price to $20 from $15 previously.
On September 09, 2022, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $14.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 01 ’24 when Campbell Bradley L sold 7,500 shares for $11.67 per share. The transaction valued at 87,496 led to the insider holds 886,654 shares of the business.
MCGLYNN MARGARET G sold 7,500 shares of FOLD for $100,500 on Mar 05 ’24. The Director now owns 59,289 shares after completing the transaction at $13.40 per share. On Mar 04 ’24, another insider, MCGLYNN MARGARET G, who serves as the Director of the company, sold 7,500 shares for $13.29 each. As a result, the insider received 99,675 and left with 59,289 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 3004045312 and an Enterprise Value of 3162900224. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.52 while its Price-to-Book (P/B) ratio in mrq is 18.64. Its current Enterprise Value per Revenue stands at 7.92 whereas that against EBITDA is -48.2.
Stock Price History:
Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.70. The 50-Day Moving Average of the stock is -15.47%, while the 200-Day Moving Average is calculated to be -16.86%.
Shares Statistics:
For the past three months, FOLD has traded an average of 3.04M shares per day and 3057500 over the past ten days. A total of 293.59M shares are outstanding, with a floating share count of 286.57M. Insiders hold about 2.98% of the company’s shares, while institutions hold 106.56% stake in the company. Shares short for FOLD as of 1713139200 were 31317181 with a Short Ratio of 10.29, compared to 1710460800 on 32398992. Therefore, it implies a Short% of Shares Outstanding of 31317181 and a Short% of Float of 10.65.
